학술논문
ctDNA Dynamics, Prognostic Markers, and Mechanisms of Resistance in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION Trial.
Document Type
Article
Author
Xiuning Le; Garassino, Marina Chiara; Myung-Ju Ahn; Felip, Enriqueta; Cortot, Alexis B.; Hiroshi Sakai; Mazières, Julien; Thomas, Michael; Viteri, Santiago; Conte, Pierfranco; Chih-Hsin Yang, James; Iams, Wade Thomas; Griesinger, Frank; Braggio, Danielle; Stroh, Christopher; Juraeva, Dilafruz; Wang, Danyi; Johne, Andreas; Paik, Paul K.
Source
Journal of Oncology Navigation & Survivorship; Nov2023, Vol. 14 Issue 11, p352-353, 2p
Subject
Language
ISSN
21660999
Abstract
Copyright of Journal of Oncology Navigation & Survivorship is the property of Amplity Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)